These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87. NICE recommends three more treatments for atopic dermatitis. Wise J BMJ; 2022 Jun; 377():o1618. PubMed ID: 35772780 [No Abstract] [Full Text] [Related]
88. Review of Ethnoracial Representation in Clinical Trials (Phases 1 Through 4) of Atopic Dermatitis Therapies. Arbuiso S; Gorgy M; Shah S; Cline A; Moy J Cutis; 2022 Apr; 109(4):233-234. PubMed ID: 35659841 [No Abstract] [Full Text] [Related]
89. In Vitro Trials: The Dawn of a New Era for Drug Discovery in Atopic Dermatitis? Giacomelli R; Fargnoli MC J Pharmacol Exp Ther; 2023 Feb; 384(2):245-247. PubMed ID: 36653181 [No Abstract] [Full Text] [Related]
90. Atopic dermatitis: time for tailored therapy. Mennini M; Di Nardo G; Fiocchi AG Lancet; 2022 Jul; 400(10348):252-253. PubMed ID: 35871800 [No Abstract] [Full Text] [Related]
91. [Atopic dermatitis-Spoilt for choice or entrance into a personalized treatment?]. Biedermann T; Werfel T Dermatologie (Heidelb); 2022 Jul; 73(7):511-512. PubMed ID: 35925207 [No Abstract] [Full Text] [Related]
92. Obesity can turn a therapy into an antitherapy in atopic dermatitis. Cook ECL; Redondo-Urzainqui A; Iborra S Allergy; 2022 Nov; 77(11):3473-3475. PubMed ID: 35989563 [No Abstract] [Full Text] [Related]
93. Leukotriene Receptor Antagonists and the Risk of Neuropsychiatric Disease: Could There Be a Genetic Predisposition? Larenas-Linnemann D J Allergy Clin Immunol Pract; 2021 Dec; 9(12):4298-4299. PubMed ID: 34893190 [No Abstract] [Full Text] [Related]
94. Written action plans should be comprehensive and evidence-based. Fleischer AB J Am Acad Dermatol; 2011 Nov; 65(5):1059. PubMed ID: 22000872 [No Abstract] [Full Text] [Related]
95. Is Montelukast Benefical in Children With Atopic Dermatitis? Lee AY Allergy Asthma Immunol Res; 2016 Jul; 8(4):279-81. PubMed ID: 27126720 [No Abstract] [Full Text] [Related]
96. Comment on fracture risks in patients with atopic dermatitis: A nationwide matched cohort study. Lin YP; Lee YT; Lee YH; Wei JC Ann Allergy Asthma Immunol; 2022 Feb; 128(2):230. PubMed ID: 35090669 [No Abstract] [Full Text] [Related]
97. Comment on 'Position statement on the role of nurses in therapeutic patient education in atopic dermatitis'. Thompson DL J Eur Acad Dermatol Venereol; 2022 May; 36(5):e341-e342. PubMed ID: 34753199 [No Abstract] [Full Text] [Related]
98. Response to comment by Thompson on 'Position Statement on the Role of Nurses in Therapeutic Patient Education in Atopic Dermatitis'. Thormann K; Simon D J Eur Acad Dermatol Venereol; 2022 May; 36(5):e342-e343. PubMed ID: 34753212 [No Abstract] [Full Text] [Related]
99. Food allergy and atopic dermatitis: Prediction, progression, and prevention. Mastrorilli C; Caffarelli C; Hoffmann-Sommergruber K Pediatr Allergy Immunol; 2017 Dec; 28(8):831-840. PubMed ID: 29117431 [TBL] [Abstract][Full Text] [Related]
100. Effect of Oral Administration of a Mixture of Probiotic Strains on SCORAD Index and Use of Topical Steroids in Young Patients With Moderate Atopic Dermatitis: A Randomized Clinical Trial. Navarro-López V; Ramírez-Boscá A; Ramón-Vidal D; Ruzafa-Costas B; Genovés-Martínez S; Chenoll-Cuadros E; Carrión-Gutiérrez M; Horga de la Parte J; Prieto-Merino D; Codoñer-Cortés FM JAMA Dermatol; 2018 Jan; 154(1):37-43. PubMed ID: 29117309 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]